Peer-reviewedCC BY 4.0PLOS One
Editorial Note: Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
Related
- Development and Validation of a Real-Time One-Pot RPA-CRISPR/Cas-Based Assay for Detection of ‘Candidatus Liberibacter Asiaticus,’ the Agent Associated with Citrus Greening Disease or Huanglongbing (HLB)
- Validation of a quantitative PCR assay for the detection and quantification of the nematode Litylenchus crenatae in American beech leaf tissue
- Exercise-Associated Gut Microbiota Remodeling and Cardiovascular Protection: Potential Mechanisms Involving Inflammatory Regulation
- Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: An Integrated Narrative Review from Molecular Mechanisms to Nutritional and Bioactive Strategies
- Stage-specific transcriptional atlas of goose satellite cells uncovers sex-biased molecular dynamics associated with embryonic skeletal muscle development
BibTeX
@article{editors2026editorial,
title = {{Editorial Note: Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)}},
author = {The PLOS One Editors},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0358531},
url = {https://doi.org/10.1371/journal.pone.0358531},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial Note: Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
AU - The PLOS One Editors
PY - 2026
DA - 2026/09/18
JO - PLOS One
DO - 10.1371/journal.pone.0358531
UR - https://doi.org/10.1371/journal.pone.0358531
SN - 1932-6203
ER -